SLIDE 1
2 the “final” privacy, security and breach notification provisions of HIPAA, HITECH and the Genetic Information Nondiscrimination Act (GINA). As of the 23rd of September 2013, this rule is in full effect and other than certain “grandfathered” agreements, all covered entities and their business associates fall under its provisions. The Final Privacy Rule makes business associates of covered entities directly liable for compliance with certain of the HIPAA Privacy and Security Rules’ requirements. It strengthens the limitations on the use and disclosure of PHI and prohibits the sale of PHI without individual authorization. It expands individuals’ rights to receive electronic copies of their health information and to restrict disclosures to a health plan concerning treatment for which the individual has paid out of pocket in full. It requires modifications to, and redistribution of, a covered entity’s notice of privacy practices. It modifies the individual authorization and other requirements to facilitate research and disclosure of child immunization proof to schools, and to enable access to decedent information by family members or others. It also adopts additional HITECH enhancements to the Enforcement Rule like the provisions addressing enforcement of noncompliance with the HIPAA Rules due to willful neglect. The Omnibus Rule also incorporates the increased and tiered civil money penalty structure provided by the HITECH Act, and replaces the breach notification rule’s “harm” threshold in an attempt to provide a more objective standard. Finally, it prohibits most health plans from using or disclosing genetic information for underwriting purposes.
- A. Business Associates
HIPAA permits a covered entity to disclose PHI to a business associate, and allow a business associate to create, receive, maintain, or transmit PHI on its behalf, provided the covered entity
- btains satisfactory assurances in the form of a contract or other arrangement that the business
associate will appropriately safeguard the information. ‘‘Business associate’’ is defined to include a person/entity who performs functions or activities on behalf of, or certain services for, a covered entity that involve the use or disclosure of PHI. Such entities include, inter alia, billing companies, electronic records management companies, Patient Safety Organizations, Health Information Organizations (HIO), E-Prescribing Gateways, other entities that provide data transmission services with respect to protected health information to a covered entity whose activities require routine access to such protected health information; and entities who offer a personal health record to one or more individuals on behalf of a covered entity. The definitions
- f HIO and “routine access” are purposefully vague. The former is seen as an evolving one
based on practice and technology, and the latter is to be determined on a case-by-case basis. Accordingly, an entity that acts as a conduit for PHI, but does sample the data for integrity purposes may, or may not be a business associate, depending on its relationship to covered entities, how often in accesses the PHI and what its responsibility for maintaining the data may
- be. However, both the guidance and prudence suggest that the “conduit” exception is a narrow
- ne designed for internet service providers and the like. An entity that maintains a covered